Review
doi: 10.1016/j.urolonc.2005.05.007.
Current clinical trials in renal cell carcinoma
Affiliations
- PMID: 16018946
- DOI: 10.1016/j.urolonc.2005.05.007
Item in Clipboard
Review
Current clinical trials in renal cell carcinoma
Urol Oncol.
2005 Jul-Aug.
Abstract
The treatment of renal cell carcinoma remains primarily surgical. Consequently, it is not surprising that urologists have been active in the design and operation of clinical trials for patients with kidney cancer. Currently, clinical trial efforts of the urologic community are focused on the adjuvant setting in patients undergoing nephrectomy at high risk for recurrence or metastasis. As newer agents become available and are applied earlier during the course of the disease, the involvement of urologists in clinical trials in renal cell carcinoma will increase. This review highlights several key trials currently available for patients with kidney cancer.
Similar articles
-
High-dose interleukin-2 in metastatic renal cell carcinoma.J Clin Oncol. 2005 Sep 20;23(27):6797-8; author reply 6798-9. doi: 10.1200/JCO.2005.02.1709. J Clin Oncol. 2005. PMID: 16170190 No abstract available.
-
Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.Expert Rev Anticancer Ther. 2007 Dec;7(12):1749-61. doi: 10.1586/14737140.7.12.1749. Expert Rev Anticancer Ther. 2007. PMID: 18062749 Review.
-
Node positive renal cell cancer. Who can be helped?Eur Urol. 2007 Jun;51(6):1477-8. doi: 10.1016/j.eururo.2007.01.034. Epub 2007 Jan 12. Eur Urol. 2007. PMID: 17240037 No abstract available.
-
Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials.Eur Urol. 2010 Dec;58(6):819-28. doi: 10.1016/j.eururo.2010.08.029. Epub 2010 Aug 27. Eur Urol. 2010. PMID: 20828919 Review.
-
Rebuttal from authors re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1477-8.Eur Urol. 2007 Jun;51(6):1478-80. doi: 10.1016/j.eururo.2007.01.067. Epub 2007 Jan 30. Eur Urol. 2007. PMID: 17275988 No abstract available.
Cited by
-
Adjuvant therapy for high-risk renal cell carcinoma patients.Curr Urol Rep. 2007 Jan;8(1):19-30. doi: 10.1007/s11934-007-0017-5. Curr Urol Rep. 2007. PMID: 17239313 Review.
-
Systemic adjuvant therapies in renal cell carcinoma.Oncol Rev. 2012 Oct 8;6(2):e18. doi: 10.4081/oncol.2012.e18. eCollection 2012 Oct 2. Oncol Rev. 2012. PMID: 25992216 Free PMC article. Review.
-
Adjuvant therapy for renal cell carcinoma.Curr Oncol Rep. 2008 May;10(3):245-52. doi: 10.1007/s11912-008-0037-4. Curr Oncol Rep. 2008. PMID: 18765155 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
